Baransel Kamaz

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Peripheral Blood

Coronavirus Disease

Top Venues

Science translational medicine

Brigham and Women's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital Jan 01 2019

United States

Postdoctoral Researcher :: Medicine/Hematology

Publications

Rathnam K Venkat, Robert A Redd, Amyah C Harris, Martin J Aryee, Anna E Marneth, Baransel Kamaz, Chulwoo J Kim, Mohammed Wazir, Lachelle Dawn Weeks, Maximilian Stahl, Daniel J DeAngelo, R Coleman Lindsley, Marlise R Luskin, Gabriela S Hobbs, Joan How
Risk of Bleeding in Essential Thrombocythemia Patients with Extreme Thrombocytosis. Blood advances (2024)
Mathieu Gigoux, Morten Orebo Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe, Cansu Cimen Bozkus, Levi Mark Mangarin, David Redmond, Svena Verma, Sara Schad, Mariam M George, Divya Venkatesh, Arnab Ghosh, David Hoyos, Zaki Molvi, Baransel Kamaz, Anna E Marneth, William Duke, Matthew Joseph Leventhal, Max Jan, Vincent T Ho, Gabriela S Hobbs, Trine Alma Knudsen, Vibe Skov, Lasse Kjær, Thomas Stauffer Larsen, Dennis Lund Hansen, R Coleman Lindsley, Hans Carl Carl Hasselbalch, Jacob H Grauslund, Thomas L Lisle, Özcan Met, Patrick Wilkinson, Benjamin Greenbaum, Manuel A Sepulveda, Timothy A Chan, Raajit Rampal, Mads Hald Andersen, Omar Abdel-Wahab, Nina Bhardwaj, Jedd D Wolchok, Ann Mullally, Taha Merghoub
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine 14 (649) (2022)
Baransel Kamaz, Ann Mullally
COVID-19 and myeloproliferative neoplasms: some considerations. Leukemia 35 (1) (2020)